| 臺大學術典藏 |
2020-04-10T12:15:59Z |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Chen Y.-C.; Ohishi N.; O’Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Frenette C.; Lin Z.-Z.; YU-YUN SHAO; Wan P.; Ma J.; Lyashchenko S.K.; Gansukh B.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Abou-Alfa G.K.;Yen C.-J.;Hsu C.-H.;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Yu-Yun Shao;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Abou-Alfa G.K.; Yen C.-J.; Hsu C.-H.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A. |
| 臺大學術典藏 |
2020-04-10T12:15:58Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Yu-Yun Shao;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; YU-YUN SHAO; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2020-04-10T12:15:58Z |
Right or left? Side selection for a totally implantable vascular access device: A randomised observational study
|
Lin W.-Y.;Lin C.-P.;Hsu C.-H.;Lee Y.-H.;Lin Y.-T.;Hsu M.-C.;Yu-Yun Shao; Lin W.-Y.; Lin C.-P.; Hsu C.-H.; Lee Y.-H.; Lin Y.-T.; Hsu M.-C.; YU-YUN SHAO |
| 臺大學術典藏 |
2020-04-10T12:15:57Z |
Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure
|
Liu T.-H.;Hsu C.-H.;Yu-Yun Shao; Liu T.-H.; Hsu C.-H.; YU-YUN SHAO |
| 臺大學術典藏 |
2020-04-10T12:15:57Z |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Yu-Yun Shao;Hsieh M.-S.;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; YU-YUN SHAO; Hsieh M.-S.; Wang H.-Y.; Li Y.-S.; Lin H.; Hsu H.-W.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:56Z |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Lu L.-C.;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Yu-Yun Shao;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; YU-YUN SHAO; Liu T.-H.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Liu T.-H.;Yu-Yun Shao;Lu L.-C.;Shen Y.-C.;Hsu C.;Lin Z.-Z.;Hsu C.-H.;Cheng A.-L.; Liu T.-H.; YU-YUN SHAO; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Potent activity of composite cyclin dependent kinase inhibition against hepatocellular carcinoma
|
Yu-Yun Shao;Li Y.-S.;Hsu H.-W.;Lin H.;Wang H.-Y.;Wo R.R.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Li Y.-S.; Hsu H.-W.; Lin H.; Wang H.-Y.; Wo R.R.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.;Lin C.-C.;Lin C.-Y.;Hsieh M.-S.;Kuo H.-Y.;Lien M.-Y.;Yu-Yun Shao;Huang T.-C.;Hsu C.-H.; Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; YU-YUN SHAO; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:53Z |
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
|
Yu-Yun Shao;Liu T.-H.;Hsu C.;Lu L.-C.;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-09T09:42:28Z |
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials
|
Shao, Y.-Y.; Shau, W.-Y.; Chan, S.-Y.; Lu, L.-C.; Hsu, C.-H.; Cheng, A.-L. |
| 臺大學術典藏 |
2020-04-09T09:39:09Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao, Y. Y.; Chen, B. B.; Ou, D. L.; Lin, Z. Z.; Hsu, C. H.; Wang, M. J.; Cheng, A. L.; Hsu, C. |
| 臺大學術典藏 |
2020-04-09T09:31:03Z |
Key opioid prescription concerns in cancer patients: A nationwide study
|
Shao, Y. Y.; Lin, C. P.; Hsu, C. H.; Fu, W. M.; Chen, H. M.; Lee, Y. H.; Lai, M. S. |
| 臺大學術典藏 |
2020-04-08T02:10:16Z |
Drug-loaded hyaluronic acid hydrogel as a sustained-release regimen with dual effects in early intervention of tendinopathy
|
Hsiao M.-Y.;Lin A.-C.;Liao W.-H.;Tyng-Guey Wang;Hsu C.-H.;Chen W.-S.;Lin F.-H.; Hsiao M.-Y.; Lin A.-C.; Liao W.-H.; TYNG-GUEY WANG; Hsu C.-H.; Chen W.-S.; Lin F.-H. |
| 臺大學術典藏 |
2020-04-08T01:10:30Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Yu, S.-L.; Yang, T.-Y.; Chang, G.-C.; Chang, G.-C.;Yang, T.-Y.;Yu, S.-L.;Chen, H.-W.;Chen, J.J.W.;Su, K.-Y.;Hsu, C.-H.;Chen, K.-C.;Tseng, J.-S.;Hsu, K.-H.;Huang, Y.-H.; Huang, Y.-H.; Hsu, K.-H.; Tseng, J.-S.; Chen, K.-C.; Hsu, C.-H.; Su, K.-Y.; Chen, J.J.W.; Chen, H.-W. |
| 臺大學術典藏 |
2020-04-07T13:17:43Z |
Drug-loaded hyaluronic acid hydrogel as a sustained-release regimen with dual effects in early intervention of tendinopathy
|
Hsiao M.-Y.; Lin A.-C.; Liao W.-H.; TYNG-GUEY WANG; Hsu C.-H.; Chen W.-S.; Lin F.-H. |
| 臺大學術典藏 |
2020-04-07T13:15:18Z |
The effect of the repression of oxidative stress on tenocyte differentiation: A preliminary study of a rat cell model using a novel differential tensile strain bioreactor
|
Liu L.; Lin F.-H.; Iafisco M.; Gefen A.; Wu Y.-W.; He C.-K.; Hsu C.-H.; Ming-Yen Hsiao;Lin P.-C.;Liao W.-H.;Chen W.-S.;Hsu C.-H.;He C.-K.;Wu Y.-W.;Gefen A.;Iafisco M.;Liu L.;Lin F.-H.; MING-YEN HSIAO; Lin P.-C.; Liao W.-H.; Chen W.-S. |
| 臺大學術典藏 |
2020-04-07T07:54:50Z |
Family-centered care improved neonatal medical and neurobehavioral outcomes in preterm infants: Randomized controlled trial
|
Yu Y.-T.; Hsieh W.-S.; Hsu C.-H.; Lin Y.-J.; Lin C.-H.; Hsieh S.; LU LU; Cherng R.-J.; Chang Y.-J.; Fan P.-C.; Yao N.-J.; Chen W.J.; Jeng S.-F. |
| 臺大學術典藏 |
2020-03-31T03:59:41Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.;Lin C.-C.;Jang-Ming Lee;Chang Y.-L.;Hsu C.-H.;Tsai Y.-C.;Lee Y.-C.;Cheng J.C.-H.; Hsu F.-M.; Lin C.-C.; JANG-MING LEE; Chang Y.-L.; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:39Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Cheng J.C.-H.; Tsai Y.-C.; Wu J.-K.; Lin C.-C.; Hsu C.-H.; JANG-MING LEE; Lee Y.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:34Z |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Chang Y.-L.; Wang H.-P.; Hsu C.-H.; JANG-MING LEE; Cheng M.-F.; Yen R.-F.; Wu Y.-W.; Chung C.-S.; Yen T.-J. |
| 臺大學術典藏 |
2020-03-31T03:59:26Z |
Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy
|
Hsu C.-H.; Koong A.C.; Chang D.T.; Chia-Hsien Cheng J.; Huang P.-M.; JANG-MING LEE; Tsai C.-L.; Wu J.-K.; Lu S.-L.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:26Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.;Cheng J.C.-H.;Tsai C.-L.;Jang-Ming Lee;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; JANG-MING LEE; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; Chang Y.-L.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:24Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Yeh K.-H.; Cheng A.-L.; Wang H.-P.; Cheng J.C.-H.; Hsu F.-M.; JANG-MING LEE; Huang P.-M.; Chang C.-H.; Lin C.-C.; Hsieh M.-S.; Guo J.-C.; Huang T.-C. |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Hsu C.-H.;Jang-Ming Lee; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
|
Huang P.-M.;Hsu F.-M.;Lin C.-C.;Hsu C.-H.;Cheng J.C.-H.;Jang-Ming Lee; Huang P.-M.; Hsu F.-M.; Lin C.-C.; Hsu C.-H.; Cheng J.C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Jang-Ming Lee;Huang P.-M.;Hsu C.-H.;Lin C.-C.;Chang Y.-L.;Hsieh M.-S.;Cheng J.C.-H.; Lu S.-L.; Hsu F.-M.; Tsai C.-L.; JANG-MING LEE; Huang P.-M.; Hsu C.-H.; Lin C.-C.; Chang Y.-L.; Hsieh M.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; JANG-MING LEE; Wang H.-P.; Chia-Hsien Cheng J.; Wu Y.-C.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Jang-Ming Lee;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-30T13:03:15Z |
Drug-loaded hyaluronic acid hydrogel as a sustained-release regimen with dual effects in early intervention of tendinopathy
|
Lin F.-H.; WEN-SHIANG CHEN; Hsiao M.-Y.;Lin A.-C.;Liao W.-H.;Wang T.-G.;Hsu C.-H.;Wen-Shiang Chen;Lin F.-H.; Hsiao M.-Y.; Lin A.-C.; Liao W.-H.; Wang T.-G.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-30T08:51:15Z |
Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery
|
Lin C.-C.; Cheng J.-C.-H.; Wang Y.-H.; Chuang T.-H.; JIN-SHING CHEN; Hsu H.-H.; Huang P.-M.; Kuo S.-W.; Lee Y.-C.; Hsu C.-H.; Wu M.-T.; Shun C.-T.; Yang P.-W.; Yang S.-Y.; Lee J.-M.; Lee J.-M.;Yang S.-Y.;Yang P.-W.;Shun C.-T.;Wu M.-T.;Hsu C.-H.;Lin C.-C.;Cheng J.-C.-H.;Wang Y.-H.;Chuang T.-H.;Jin-Shing Chen;Hsu H.-H.;Huang P.-M.;Kuo S.-W.;Lee Y.-C. |
| 臺大學術典藏 |
2020-03-30T08:51:01Z |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu C.-H.;Tseng C.-H.;Chiang C.-J.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.-H.;Chiu C.-H.;Huang M.-S.;Yu C.-J.;Tsai Y.-H.;Jin-Shing Chen;Tsai C.-M.;Chou T.-Y.;Lin K.-C.;Tsai M.-H.;Lee W.-C.;Ku H.-Y.;Liu T.-W.;Yang T.-Y.;Chang G.-C.; Chang G.-C.; Hsu C.-H.; Tseng C.-H.; Chiang C.-J.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.-H.; Chiu C.-H.; Huang M.-S.; Yu C.-J.; Tsai Y.-H.; JIN-SHING CHEN; Tsai C.-M.; Chou T.-Y.; Lin K.-C.; Tsai M.-H.; Lee W.-C.; Ku H.-Y.; Liu T.-W.; Yang T.-Y. |
| 臺大學術典藏 |
2020-03-27T05:30:12Z |
Neonatal listeriosis in Taiwan, 1990-2007
|
Yang P.-H.; Tsao P.-N.; Chou H.-C.; Chen C.-Y.; PO-REN HSUEH; Lin H.-C.; Hsu C.-H.; Jeng S.-F.; Tsai L.-Y.; Hsieh W.-S.; Yang P.-H.;Tsao P.-N.;Chou H.-C.;Chen C.-Y.;PO-REN HSUEH;Lin H.-C.;Hsu C.-H.;Jeng S.-F.;Tsai L.-Y.;Hsieh W.-S. |
| 臺大學術典藏 |
2020-03-24T04:02:54Z |
Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change
|
Lee E.Y.-H.P.; WEN-HUNG KUO; Chen C.-C.; Hsu C.-H.; Peng K.-L.; Tyan S.-W.; Tyan S.-W.;Hsu C.-H.;Peng K.-L.;Chen C.-C.;Wen-Hung Kuo;Lee E.Y.-H.P.;Shew J.-Y.;Chang K.-J.;Juan L.-J.;Lee W.-H.; Shew J.-Y.; Chang K.-J.; Juan L.-J.; Lee W.-H. |
| 臺大學術典藏 |
2020-03-23T07:19:32Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Hsu C.; Yeh K.-H.; Wu C.-Y.; CHIUN-SHENG HUANG; Yang C.-H.; Lu Y.-S.; Hsu C.-H.; Cheng A.-L.; Lin C.-C. |
| 臺大學術典藏 |
2020-03-23T07:18:46Z |
Computer-aided tumor detection in automated breast ultrasound using a 3-D convolutional neural network
|
Chang R.-F.; Lee S.H.; CHIUN-SHENG HUANG; Moon W.K.;Huang Y.-S.;Hsu C.-H.;Chang Chien T.-Y.;Chang J.M.;Lee S.H.;Chiun-Sheng Huang;Chang R.-F.; Moon W.K.; Huang Y.-S.; Hsu C.-H.; Chang Chien T.-Y.; Chang J.M. |
| 臺大學術典藏 |
2020-03-07T06:56:45Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.; Lin C.-C.; Lee J.-M.; YIH-LEONG CHANG; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-07T06:56:35Z |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
YIH-LEONG CHANG; Wang H.-P.; Hsu C.-H.; Lee J.-M.; Cheng M.-F.; Yen R.-F.; Wu Y.-W.; Chung C.-S.; Yen T.-J.; Yen T.-J.;Chung C.-S.;Wu Y.-W.;Yen R.-F.;Cheng M.-F.;Lee J.-M.;Hsu C.-H.;Yih-Leong Chang;Wang H.-P. |
| 臺大學術典藏 |
2020-03-07T06:56:24Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.;Cheng J.C.-H.;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Hsieh M.-S.;Yih-Leong Chang;Hsu F.-M.; Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; YIH-LEONG CHANG; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-07T06:56:10Z |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Hsu C.-H.;Lin C.-C.;Yih-Leong Chang;Hsieh M.-S.;Cheng J.C.-H.; Lu S.-L.; Hsu F.-M.; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Hsu C.-H.; Lin C.-C.; YIH-LEONG CHANG; Hsieh M.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:24Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
Cheng A.-L.; Chung Y.; YUNG-MING JENG; Hu F.-C.; Hsu C.; Kuo S.-H.; Chen T.-J.; Huang Y.-F.; Huang C.-Y.F.; Yeh P.-Y.; Hsu C.-H.; Hsu H.-C.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-03-06T08:25:14Z |
Clostridium difficile infection in a patient with Crohn disease
|
Hsu C.-H.; YUNG-MING JENG; Ni Y.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:13Z |
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
|
Huang H.-D.; Lu Y.-Y.; Teng Y.-C.; Lin S.-T.; Lin R.-K.; Tang F.-M.; Lee S.-B.; Hsu H.; Yu J.-C.; Hsiao P.-W.; Juan L.-J.; Lin F.-M.; Chen Y.-T.; YUNG-MING JENG; Chu C.-S.; Tsai C.-H.; Yang Y.-C.; Chen Y.-R.; Kang M.-L.; Peng K.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:08Z |
Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis
|
Teng Y.-C.; Lee C.-F.; Li Y.-S.; Chen Y.-R.; Hsiao P.-W.; Chan M.-Y.; Lin F.-M.; Huang H.-D.; Chen Y.-T.; YUNG-MING JENG; Hsu C.-H.; Yan Q.; Tsai M.-D.; Juan L.-J. |
| 臺大學術典藏 |
2020-03-06T08:25:02Z |
Changes in backscattered ultrasonic envelope statistics as a function of thrombus age: An invitro study
|
Fang J.;Chen C.-K.;Peng J.-Y.;Hsu C.-H.;Yung-Ming Jeng;Lee Y.-H.;Lin J.-J.;Tsui P.-H.; Fang J.; Chen C.-K.; Peng J.-Y.; Hsu C.-H.; YUNG-MING JENG; Lee Y.-H.; Lin J.-J.; Tsui P.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:32Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.; Lin C.-C.; Lee J.-M.; YIH-LEONG CHANG; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:22Z |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen T.-J.; Chung C.-S.; Wu Y.-W.; Yen R.-F.; Cheng M.-F.; Lee J.-M.; Hsu C.-H.; YIH-LEONG CHANG; Wang H.-P. |
| 臺大學術典藏 |
2020-03-06T05:26:14Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; YIH-LEONG CHANG; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-06T05:26:01Z |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Cheng J.C.-H.; Lin C.-C.; YIH-LEONG CHANG; Hsieh M.-S.; Hsu C.-H.; Huang P.-M.; Tsai C.-L.; Lee J.-M.; Hsu F.-M.; Lu S.-L. |
| 臺大學術典藏 |
2020-03-06T03:42:05Z |
Chinese version of the OSI: A validation study
|
Lu L.;Hsu C.H.;Shih J.B.;Li C.H.; Lu L.; Hsu C.H.; Shih J.B.; Li C.H.; LUO LU |
